UHS CFO’s comments spark concerns about cherry-picking

The latest stories trending on MedCity News.

Editor's Pick

Top Story 'We Can Be More Selective About Who We Treat': UHS CFO's Comments Spark Concerns About Cherry-Picking Last week, the CFO of Universal Health Services stated that the company chooses which patients to treat based on whose insurance plans offer the highest payments. The comments have sparked some media attention, but healthcare finance experts say the practice of cherry-picking patients is nothing new to the industry. Sponsored Content Importance of Patient Capital in Life Sciences Presented by TSX VENTURE EXCHANGE (TSXV) TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development purposes. Learn More>>

Featured News

TG Therapeutics Lands Partner to Market MS Drug in Europe and Beyond TG Therapeutics' multiple sclerosis drug Briumvi will be commercialized in Europe by Neuraxpharm. The Germany-based company paid $140 million up front for certain rights to the drug, which received European Commission approval in June. CMS Anticipates a 1.8% Decrease in Medicare Part D Monthly Premiums for 2024 The average total monthly premium for Medicare Part D coverage is expected to be $55.50 in 2024, down from $56.49 in 2023, according to CMS. Prescribing Change for the Impact Pharmacists Can Make in Healthcare Even as value-based care finds its footing and expands further, team-based approaches to care delivery incorporating pharmacists as crucial connections are already bearing results—helping provider organizations achieve 5-star CMS ratings for medication adherence, driving down costs, and driving up the quality of life for patients. Hello Alpha Unveils Female-focused Weight Management Program for Employers Hello Alpha launched Ahead with Alpha, a weight management program for employers. It offers access to primary care providers trained in obesity care, medication management through weight loss drugs like GLP-1s, nutrition counseling with a registered dietitian and progress tracking.  HerMD Snags $18M to Open More Menopause-Focused Health Centers HerMD recently raised $18 million in a Series A-1 funding round. The company offers in-person and virtual women's healthcare that focuses on menopause and sexual health. It is using its new capital to open more brick-and-mortar women's health centers across the country. EQRx's Affordable Drugs Strategy Ends in Acquisition by Revolution, Interested Only in Its Cash Revolution Medicines is acquiring EQRx in an all-stock deal bringing that company's more than $1 billion in cash. It marks the end for EQRx, a company that aimed to develop and commercialize lower-cost drugs for cancer and other diseases. From Bottlenecks to Breakthroughs: Using Technology to Transform Specialty Medication Access and Affordability We need a streamlined approach where stakeholders can perform all critical tasks — from enrollment and patient consent to prior authorization, from real-time benefit checks to financial assistance — on a central platform powered by a business rules engine, automated workflows, and real-time analytics. The New Normal in Healthcare Marketing AI can index company narratives relative to strategy, opportunities, and threats, and create benchmarks to watch over time related to sentiment, intensity, and impressions. Ultimately these can be tied back to ROI and stakeholder value that move past typical marketing performance metrics or traditional brand metrics.

Resources

MedCity Pivot Podcast: The Toxicity of Immunotherapy In this podcast we hear from Dr. Sumanta Pal, co-director of the City of Hope's Liver Cancer program as a guest after he co-authored an interesting study on immunotherapy that was published in the Lancet. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe